What Are Spindle Cells? Types, Diagnosis, and Treatment

In pathology, the term “spindle cell” describes a cell’s shape as observed under a microscope. These cells are characteristically elongated, appearing longer than they are wide, and often taper at both ends, resembling a spindle. This classification is based purely on morphology, or what the cell looks like. It is a descriptor used by pathologists when they analyze tissue samples, and this visual characteristic is the starting point for a deeper investigation.

The Nature of Spindle Cells

The term “spindle cell” is not exclusive to abnormal or diseased tissue; it is a shape shared by many normal, healthy cells. For instance, fibroblasts, which are fundamental cells in connective tissue, naturally have a spindle shape. Similarly, smooth muscle cells, responsible for involuntary movements in organs like the intestines, also exhibit this elongated form.

When cells grow uncontrollably, they can form a growth or lesion. If the cells within this lesion have a spindle shape, it is referred to as a spindle cell lesion. This term is descriptive and does not, by itself, indicate whether the growth is harmful, simply noting the shape of the cells. Because a wide array of conditions can present with spindle-shaped cells, this initial observation is a preliminary guide for pathologists. A final diagnosis requires more detailed examination and specialized testing to identify the cell’s origin.

Types of Spindle Cell Tumors

Spindle cell tumors can be either non-cancerous (benign) or cancerous (malignant), and they are classified based on the type of tissue from which they originate. The range of these tumors is broad, encompassing various structures within the body. A pathologist determines the specific tumor type by examining its features and, when necessary, performing additional tests.

Benign Tumors

Benign spindle cell tumors are non-cancerous growths that do not spread to other parts of the body. A common example is the spindle cell lipoma, a slow-growing tumor typically found in the subcutaneous tissue of the neck, shoulders, or back. These tumors are composed of a mixture of mature fat cells and uniform spindle cells. They are generally harmless and are often only removed if they cause symptoms or for cosmetic reasons. Another example is a neurofibroma, a benign tumor that grows on nerves.

Malignant Tumors

Malignant spindle cell tumors are cancers, with the majority being classified as sarcomas—cancers that arise from connective tissues like bone, muscle, fat, and cartilage. One prominent example is the Gastrointestinal Stromal Tumor (GIST), which is the most common sarcoma of the digestive tract. These tumors originate from specialized cells in the wall of the GI tract. Another type is leiomyosarcoma, an aggressive cancer of smooth muscle tissue that often develops in the uterus, abdomen, or blood vessels.

Some cancers not typically associated with connective tissue can also present with spindle-shaped cells. Spindle cell melanoma is a rare variant of skin cancer where the cancerous pigment-producing cells (melanocytes) take on an elongated appearance. Similarly, a carcinoma can sometimes be composed of spindle cells, and in these cases, pathologists describe the cells as “sarcomatoid” because they mimic the appearance of a sarcoma.

Diagnosis and Identification

A definitive diagnosis of a spindle cell tumor begins with a biopsy, where a small sample of the abnormal tissue is removed. This sample is sent to a pathologist, who first looks at the tissue under a microscope to observe the shape and arrangement of the cells. This initial microscopic examination confirms the presence of spindle cells but is not sufficient for a final diagnosis.

Because many different types of tumors can be composed of spindle-shaped cells, determining the cell’s origin is required for an accurate diagnosis. To achieve this, pathologists rely on a technique called immunohistochemistry (IHC). This laboratory method uses antibodies designed to detect specific proteins, known as markers, on or inside the cells. This process acts like a molecular fingerprinting system.

The tissue sample from the biopsy is treated with these antibodies, which are linked to a dye. If a specific protein is present in the cells, the antibody will bind to it, causing the cells to change color when viewed under the microscope. For example, a tumor from muscle tissue might test positive for a protein called desmin, while a neural tumor would be positive for a marker called S-100 protein. By using a panel of different antibodies, a pathologist can precisely identify the cell type.

Common Treatment Approaches

The treatment for a spindle cell tumor is highly individualized and depends on several factors, including the specific type of tumor, its size, location, and whether it is benign or malignant. For malignant tumors, the stage of the cancer—meaning how far it has spread—is also a major consideration. A team of medical professionals determines the most suitable approach for each patient.

For localized malignant spindle cell tumors, surgery is often the primary treatment. The goal is to remove the entire tumor along with a margin of surrounding healthy tissue to ensure that no cancer cells are left behind. In many cases, surgery alone can be curative, especially if the tumor is small and has not invaded nearby structures.

Following surgery, radiation therapy may be used to eliminate any remaining cancer cells in the area where the tumor was removed. This treatment uses high-energy rays to destroy cancer cells and is useful for reducing the risk of the cancer returning. For tumors that are large or difficult to remove surgically, radiation might be administered before the operation to shrink the tumor.

Systemic treatments travel through the bloodstream to reach cancer cells throughout the body. Chemotherapy involves the use of drugs to kill rapidly dividing cells, a hallmark of cancer. Targeted therapy has emerged as a significant option for specific types of spindle cell tumors. For example, many Gastrointestinal Stromal Tumors (GISTs) are driven by mutations in a protein called KIT, and targeted drugs that block this protein’s activity can be effective in controlling the disease.

What Is Glyphosate Poisoning in Cattle?

Immunotherapy for Melanoma: How It Works & What to Expect

What Is Paclitaxel Premedication and Why Is It Needed?